bupropion

(redirected from Aplenzin)
Also found in: Medical.

bu·pro·pi·on

 (byo͞o-prō′pē-ŏn′)
n.
A drug, C13H18ClNO, used in its hydrochloride form for the treatment of depression and as an aid in smoking cessation. It is a weak inhibitor of norepinephrine and dopamine reuptake in the central nervous system.

[bu(tyl) + propi(ophen)on(e), a ketone (propio(nic acid) + phen(yl) + -one).]

bupropion

(bjuːˈprəʊpɪɒn)
n
an antidepressant drug used to help people stop smoking
Translations

bupropion

n bupropión m
Mentioned in ?
References in periodicals archive ?
04% Retin-A Micro Gel Fenofibric Acid Delayed-Release Trilipix Delayed- Capsules, 45 mg, 135 mg Release Capsules Metformin Hydrochloride Extended-Release Glumetza Tablets USP, 500 mg, 1,000 mg Tablets Donepezil Hydrochloride Tablets, 23 mg Aricept Tablets AUGUST 2013 Bupropion Hydrobromide Extended-Re- Aplenzin IeaseTablets,174 mg, 522 mg Extended Release Tablets Naproxen and Esomeprazole Magnesium Vimovo Delayed- Delayed-ReleaseTablets, 375 mg/20 mg Release Tablets (base), 500 mg/20 mg (base) Norethindrone and Ethinyl Estradiol Tablets Ovcon-50 USP, 1 mg/0.
The FDA has also cleared Aplenzin (sanofi-aventis U.